Cardiac Rhythm Management Devices Market to surpass $ 13.7 Bn by 2025

December 31, 2019


According to the research report titled ‘Cardiac Rhythm Management Devices Market Size By Product (Pacemakers {Implantable Pacemakers, External Pacemakers}, Defibrillators (Implantable Cardioverter Defibrillator [ICDs], {Subcutaneous Implantable Cardioverter Defibrillator, Transvenous Implantable Cardioverter Defibrillator {Single-chamber ICDs, Dual-chamber ICDs}, External Defibrillator [ED] {Manual ED, Automated ED {Semi-automated External Defibrillator, Fully Automated External Defibrillator} Wearable Cardioverter Defibrillator, Cardiac Resynchronization Therapy Devices [CRTs] {CRT-D, CRT-P}Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Poland, Japan, China, India, Australia, South Korea, Taiwan, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, available at MarketStudyReport.com, the global cardiac rhythm management devices market is expected to cross USD 13.7 billion by the year 2025.
 

Growing occurrence of cardiovascular diseases, coupled with rising number of patients suffering from recurrent arrhythmias are driving the cardiac rhythm management devices market growth. NCBI (National Centre for Biotechnology & Information) estimates that up to 17 million deaths occur annually due to cardiovascular disorders of which 25% deaths are caused by sudden cardiac arrests. Thus, increasing awareness regarding healthy lifestyle and favorable government initiatives to reduce death rate are aiding the expansion of the market.
 

As per product, cardiac rhythm management devices industry from pacemakers segment is anticipated to accrue USD 4.3 billion by the year 2025. The growth is attributed to surging need of pacemakers for treatment of arrhythmias, along with rising prevalence of bradycardia, cardiomyopathy and congestive heart failure.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2270778/
 

Considering geographical landscape, North America market was worth USD 5.7 billion in 2018 and is expected to maintain its dominance during the estimated timeframe. Favorable reimbursement policies, coupled with availability of state-of-the-art healthcare facilities are contributing towards the popularity of the product across the region, thereby driving the growth of North America cardiac rhythm management devices market.
 

The prominent companies operating in cardiac rhythm management devices industry are Abbott, Medtronic, Koninklijke Philips N.V., ZOLL Medical Corp., SCHILLER, ABIOMED, BIOTRONIK, Liva Nova, and Boston Scientific Corp. among others.


Frequently Asked Questions (FAQ) :

Growing occurrence of cardiovascular diseases coupled with rising number of patients suffering from recurrent arrhythmias are driving the cardiac rhythm management devices market growth. NCBI (National Centre for Biotechnology & Information) estimates that up to 17 million deaths occur annually due to cardiovascular disorders in which 25% deaths are caused by cardiac arrests. Thus, increasing awareness regarding healthy lifestyle and favorable government initiatives to reduce death rate are aiding the expansion of the market.
Cardiac rhythm management devices industry from pacemakers segment is anticipated to accrue USD 4.3 billion by the year 2025. The growth is attributed to surging need of pacemakers for treatment of arrhythmias, along with rising prevalence of bradycardia, cardiomyopathy, and congestive heart failure.
North America market was worth USD 5.7 billion in 2018 and is expected to maintain its dominance during the estimated timeframe. Favorable reimbursement policies coupled with availability of state-of-the-art healthcare facilities are contributing towards the popularity of the product across the region, thereby driving the growth of North America cardiac rhythm management devices market.
The prominent companies operating in cardiac rhythm management devices industry are Abbott, Medtronic, Koninklijke Philips N.V., ZOLL Medical Corp., SCHILLER, ABIOMED, BIOTRONIK, Liva Nova, and Boston Scientific Corp. among others.